Jump to content

Recommended Posts

Posted

Screenshot_1.jpg.15807c5e42e972fc94f3944557407e0d.jpg

 

 

The condition has put significant strain on patients and society — at a global economic cost of about $1 trillion a year, a new report estimates.

 

Aug. 9, 2024

 

About 400 million people worldwide have been afflicted with long Covid, according to a new report by scientists and other researchers who have studied the condition. The team estimated that the economic cost — from factors like health care services and patients unable to return to work — is about $1 trillion worldwide each year, or about 1 percent of the global economy.

...

About 6 percent of adults globally have had long Covid.

The authors evaluated scores of studies and metrics to estimate that as of the end of 2023, about 6 percent of adults and about 1 percent of children — or about 400 million people — had ever had long Covid since the pandemic began. They said the estimate accounted for the fact that new cases slowed in 2022 and 2023 because of vaccines and the milder Omicron variant.
...

Many people have not fully recovered.

The authors cited studies suggesting that only 7 percent to 10 percent of long Covid patients fully recovered two years after developing long Covid. They added that “some manifestations of long Covid, including heart disease, diabetes, myalgic encephalomyelitis and dysautonomia are chronic conditions that last a lifetime.”
...

Treatment remains one of the biggest challenges.

There is still too little known about treating long Covid, the authors wrote, and there remains a “near-total absence of evidence from randomized clinical trials to guide treatment decisions.”

 
(more)
 
New York Times
 
 
 
 
 
Posted

Long COVID is a $1 trillion problem with no cure. Experts plead for governments to wake up

August 9, 2024

 

...

This form of COVID is particularly perilous because, for many people, its symptoms may last years (or a lifetime) and their effects may trigger all sorts of associated problems and costs. Long COVID “affects nearly every organ system,” the review notes, including the cardiovascular, immune, gastrointestinal and reproductive systems. While more than 200 symptoms have been identified, common symptoms include memory problems, difficulty concentrating, fatigue, heart palpitations, chronic cough, shortness or breath and recurring headaches.

 

Chillingly, most people who develop long COVID did not have particularly vicious cases of the virus initially. That’s in part because so many more people experience a mild form of COVID rather than a severe one. (Across most studies, long COVID risk does increase with the severity of the initial infection.) And each time people become reinfected with the virus, they’re at risk of developing long COVID, even if they didn’t experience it previously.

 

The authors note that studies on recovery from long COVID are “sparse and inconsistent.” But those that have closely evaluated individual manifestations of the virus have found recovery rates to be fairly low at one year, and only 7% to 10% fully recovered after two years. For millions and millions of people, the debilitating effects of long COVID are just that.

 

(more)

 

Fortune

https://fortune.com/well/article/long-covid-cost-1-trillion-treatment-cure/

 

Posted

Except numerous studies from various sources have consistently found that unvaccinated people become infected with COVID and also suffer Long COVID at higher rates than the vaccinated.

 

Just some of many examples:

Vaccinated People Have Up to 58% Lower Risk of Long COVID

Feb. 21, 2024 – People vaccinated against COVID-19 were significantly less likely to have long COVID during the first few years of the pandemic, a new study from Michigan shows.

...

The researchers compared vaccinated and unvaccinated people multiple ways and consistently showed at least a 40% difference in long COVID.

 

https://www.webmd.com/vaccines/covid-19-vaccine/news/20240221/vaccinated-people-lower-risk-long-covid-study

 

Getting Vaccinated May Be Your Best Protection from Long COVID

People vaccinated before their first case of COVID-19 are diagnosed with Long COVID almost four times less than unvaccinated people, suggests a large new study published Nov. 22 in the BMJ.

 

That’s not an entirely new finding. For years, studies have shown that, while vaccinated people can and do develop Long COVID, they are at lower risk than people who haven’t had their shots.

 

https://time.com/6338434/vaccination-long-covid-risk/

 

 

Long Covid and Vaccination: What You Need to Know

 

A new study adds to evidence that the shots can reduce the chances of developing one of the most dreaded consequences of Covid.

 

July 17, 2024

...

"In the new study, published in the New England Journal of Medicine, Dr. Al-Aly and his colleagues provided persuasive evidence that vaccines cut the risk of long Covid.

 

Before the vaccines were introduced, about 1 in 10 people had long Covid one year after being infected. After the shots were available, 9.5 percent of the unvaccinated developed long Covid after an infection with the Delta variant, and 7.8 percent did so after infection with the Omicron variant.

 

But among vaccinated people, only 5.3 percent developed long Covid after infection with the Delta variant, and 3.5 percent after infection with the Omicron variant.

 

New York Times

https://archive.ph/6BCEg#selection-1021.0-1033.164

 

  • Like 1
  • Thanks 1
Posted
1 hour ago, Red Phoenix said:

Imo so-called 'long COVID' is nothing more than vax-fanatic speak to obfuscate some of the adverse effects of the 'safe and effective' mRNA covid-vax.  

How do you explain cases of long Covid in unvaccinated people?

  • Like 2
Posted

Right.....  :whistling:

The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia

March 2024

 

"Vaccination against COVID-19 consistently reduced the risk of long COVID symptoms, which highlights the importance of vaccination to prevent persistent COVID-19 symptoms, particularly in adults."

...

Added value of this study

To our knowledge, this is the first multinational study to assess population-level vaccine effectiveness to prevent long COVID symptoms. Our study of more than 10 million vaccinated people and 10 million unvaccinated people, showed that COVID-19 vaccination reduces the risk of developing long COVID. Our findings were consistent across three different European countries and four databases, covering different health-care settings and national health-care policies. All vaccines reduced the risk of developing long COVID symptoms, with BNT162b2 showing slightly better effectiveness than ChAdOx1.

...

Discussion

Our analyses of more than 20 million vaccinated and unvaccinated people show the clinical effectiveness of COVID-19 vaccines to prevent the development of long COVID in three European countries (the UK, Estonia, and Spain), with overall vaccine effectiveness ranging from 29% to 52%.

 

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext

 

  • Thanks 1

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...